Track Pfizer Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Pfizer Inc. PFE.F · Stock Open Pfizer Inc. in new tab

21.81 EUR
P/E
19.26
EPS
1.15
Yield
6.88%
Safety Score
16
P/B
1.60
ROE
8.31
Beta
0.31
Loading chart...
Key Metrics
Earnings dateAug. 4, 2026
P/E19.26
EPS1.15
Book Value13.82
Price to Book1.60
Debt/Equity71.60
% Insiders0.095%
Growth
Revenue Growth0.05%
Earnings Growth-0.10%
Dividend
Dividend Yield6.88%
Annual dividends1.72 EUR
Ex-Div. DateJuly 24, 2026
Payout130.54%
5y avg Yield4.54%

DCF Valuation

Tweak assumptions to recompute fair value for Pfizer Inc. (PFE.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Pfizer Inc. Logo Pfizer Inc. Analysis (PFE.F)

United States Health Care Official Website Stock

Is Pfizer Inc. a good investment? Pfizer Inc. (PFE.F) is currently trading at 21.81 EUR.

In terms of valuation, the stock trades at a P/E ratio of 19.26. This valuation is generally in line with the broader market.

Earnings Schedule: Pfizer Inc. is expected to release its next earnings report on Aug. 4, 2026.

For income investors, Pfizer Inc. pays a dividend yield of 6.88%. With a payout ratio of 131%, the dividend appears to be under pressure.

Investor FAQ

Does Pfizer Inc. pay a dividend?

Yes, it pays an annual dividend of 1.72 EUR (6.88% yield).

What asset class is Pfizer Inc.?

Pfizer Inc. is classified as a Stock. You can compare it against 13 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 1.15.

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Exchange Ticker
SGO (Chile) PFE.SN
BER (Germany) PFE.BE
HAN (Germany) PFE.HA
HAM (Germany) PFE.HM
MEX (Mexico) PFE.MX
STU (Germany) PFE.SG
STO (Sweden) PFE.ST
VIE (Austria) PFE.VI
SAO (Brazil) PFIZ34.SA
DUS (Germany) PFE.DU
FRA (Germany) PFE.F
GER (Germany) PFE.DE
NYQ (United States) PFE
Trades
Dividend Yield
6.88%
5y avg 4.54%
Annual Dividends
1.72EUR
Next Ex. Div Date
July 24, 2026
Payout Ratio
130.54%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
0.75 EUR
June 1, 2027 (estimated) 0.3775
March 1, 2027 (estimated) 0.3768
2026
1.49 EUR
Dec. 2, 2026 (estimated) 0.3813
Sept. 1, 2026 0.3780
June 12, 2026 0.3680
March 6, 2026 0.3664
2025
1.51 EUR
Dec. 1, 2025 0.3719
Sept. 2, 2025 0.3674
June 13, 2025 0.3777
March 7, 2025 0.3970
2024
1.68 EUR
Dec. 2, 2024 0.4200
Sept. 3, 2024 0.4200
June 14, 2024 0.4200
March 1, 2024 0.4200
2023
1.64 EUR
Dec. 4, 2023 0.4100
Sept. 5, 2023 0.4100
June 9, 2023 0.4100
March 3, 2023 0.4100
2022
1.55 EUR
Dec. 5, 2022 0.4103
Sept. 6, 2022 0.3924
June 10, 2022 0.3854
March 4, 2022 0.3590
2021
1.56 EUR
Dec. 6, 2021 0.3900
Sept. 7, 2021 0.3900
June 4, 2021 0.3900
March 5, 2021 0.3900
2020
1.52 EUR
Dec. 1, 2020 0.3800
Sept. 1, 2020 0.3800
June 5, 2020 0.3800
March 6, 2020 0.3800
2019
1.77 EUR
Dec. 2, 2019 0.3600
Sept. 3, 2019 0.3600
July 31, 2019 0.3334
June 7, 2019 0.3600
March 1, 2019 0.3600
2018
1.67 EUR
Dec. 3, 2018 0.3400
Sept. 4, 2018 0.3400
June 1, 2018 0.3400
March 1, 2018 0.3400
Jan. 31, 2018 0.3148
2017
1.26 EUR
Sept. 1, 2017 0.3200
June 1, 2017 0.3200
March 1, 2017 0.3200
Jan. 31, 2017 0.2963
2016
0.90 EUR
Nov. 8, 2016 0.3000
Aug. 3, 2016 0.3000
Feb. 3, 2016 0.3000
2015
1.12 EUR
Nov. 4, 2015 0.2800
Aug. 5, 2015 0.2800
May 6, 2015 0.2800
Feb. 4, 2015 0.2800
2014
1.04 EUR
Nov. 5, 2014 0.2600
July 30, 2014 0.2600
May 7, 2014 0.2600
Feb. 5, 2014 0.2600
2013
0.96 EUR
Nov. 6, 2013 0.2400
July 31, 2013 0.2400
May 8, 2013 0.2400
Jan. 30, 2013 0.2400
2012
1.29 EUR
Nov. 7, 2012 0.2200
Aug. 1, 2012 0.2200
July 31, 2012 0.2037
May 9, 2012 0.2200
Feb. 1, 2012 0.2200
Jan. 31, 2012 0.2037
2011
0.80 EUR
Nov. 8, 2011 0.2000
Aug. 3, 2011 0.2000
May 11, 2011 0.2000
Feb. 2, 2011 0.2000
2010
0.36 EUR
Nov. 4, 2010 0.1800
Aug. 4, 2010 0.1800
Upcoming Dividends
Name Payment Date Status Amount
Pfizer Inc. Sep 01, 2026 Upcoming 0.378 EUR
Pfizer Inc. Jun 12, 2026 0.36803 EUR
Pfizer Inc. Mar 06, 2026 0.36639 EUR
Pfizer Inc. Dec 01, 2025 0.37186 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion